UnitedHealth Group Incorporated (NYSE:UNH) Holdings Decreased by LS Investment Advisors LLC

LS Investment Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 89.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,239 shares of the healthcare conglomerate’s stock after selling 18,279 shares during the quarter. LS Investment Advisors LLC’s holdings in UnitedHealth Group were worth $897,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Bar Harbor Trust Services raised its position in UnitedHealth Group by 5.2% in the second quarter. Bar Harbor Trust Services now owns 2,988 shares of the healthcare conglomerate’s stock worth $1,197,000 after acquiring an additional 147 shares in the last quarter. Bank of New York Mellon Corp increased its stake in UnitedHealth Group by 3.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 9,579,497 shares of the healthcare conglomerate’s stock worth $3,836,011,000 after purchasing an additional 354,695 shares in the last quarter. Roosevelt Investment Group LLC increased its stake in UnitedHealth Group by 0.3% in the 2nd quarter. Roosevelt Investment Group LLC now owns 65,740 shares of the healthcare conglomerate’s stock worth $26,325,000 after purchasing an additional 196 shares in the last quarter. Prentice Wealth Management LLC increased its stake in UnitedHealth Group by 10.1% in the 2nd quarter. Prentice Wealth Management LLC now owns 2,055 shares of the healthcare conglomerate’s stock worth $823,000 after purchasing an additional 188 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. increased its stake in UnitedHealth Group by 83.7% in the 2nd quarter. Edmond DE Rothschild Holding S.A. now owns 81,919 shares of the healthcare conglomerate’s stock worth $32,804,000 after purchasing an additional 37,320 shares in the last quarter. Institutional investors and hedge funds own 86.21% of the company’s stock.

Shares of UNH stock traded down $4.06 during trading hours on Wednesday, hitting $408.28. 34,323 shares of the company’s stock were exchanged, compared to its average volume of 2,984,847. The stock’s 50-day moving average is $416.38 and its 200-day moving average is $401.08. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.77 and a quick ratio of 0.77. The stock has a market cap of $384.97 billion, a price-to-earnings ratio of 27.24, a price-to-earnings-growth ratio of 1.62 and a beta of 0.77. UnitedHealth Group Incorporated has a 52 week low of $289.64 and a 52 week high of $431.36.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 EPS for the quarter, topping the consensus estimate of $4.43 by $0.27. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The company had revenue of $71.32 billion for the quarter, compared to analysts’ expectations of $69.51 billion. During the same quarter in the prior year, the business earned $7.12 earnings per share. The business’s revenue for the quarter was up 14.8% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 18.74 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 21st. Stockholders of record on Monday, September 13th were paid a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend was Friday, September 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.36%.

Several equities analysts have weighed in on UNH shares. Stephens lifted their target price on UnitedHealth Group from $440.00 to $460.00 and gave the company an “overweight” rating in a research note on Friday, July 16th. Oppenheimer reissued a “buy” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Thursday, July 15th. Credit Suisse Group boosted their target price on UnitedHealth Group from $430.00 to $462.00 and gave the stock an “outperform” rating in a report on Friday, July 16th. Barclays boosted their target price on UnitedHealth Group from $435.00 to $465.00 and gave the stock an “overweight” rating in a report on Friday, July 16th. Finally, Morgan Stanley cut their price target on UnitedHealth Group from $515.00 to $488.00 and set an “overweight” rating for the company in a report on Tuesday, August 31st. Three research analysts have rated the stock with a hold rating, twenty have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $444.04.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 60,000 shares of the stock in a transaction dated Friday, July 16th. The stock was sold at an average price of $420.62, for a total value of $25,237,200.00. Following the transaction, the director now owns 941,560 shares of the company’s stock, valued at $396,038,967.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Andrew Witty sold 6,000 shares of the stock in a transaction dated Wednesday, July 21st. The shares were sold at an average price of $414.15, for a total value of $2,484,900.00. The disclosure for this sale can be found here. Insiders sold 101,438 shares of company stock worth $42,396,929 in the last three months. Insiders own 0.55% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: Federal Reserve

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.